Clinical Trial

Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to investigate the safety and tolerability of YN001 in combination with rosuvastatin, so as to provide evidence for the feasibility of YN001 combined with statins in subsequent clinical trials.
Trial Details
NCT Number NCT07309042
Lead Sponsor Beijing Inno Medicine Co., Ltd.
Conditions Atherosclerotic Cardiovascular Diseases, Cerebrovascular Diseases
Enrollment 24 participants
Start Date 2025-12
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-12-30